2017
DOI: 10.5603/njo.2017.0005
|View full text |Cite
|
Sign up to set email alerts
|

Are molecular target therapies limited by cardiotoxicity — causes and symptoms of cardiovascular damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 28 publications
0
0
0
Order By: Relevance
“…Cardiologists sometimes joke that it is easier to fix the heart than cure cancer; however, we all know from epidemiological data that the death toll of late cardiac toxicity among cancer survivors is substantial. It holds true not only for the old cytotoxic chemotherapy but also for many novel targeted treatments [6].…”
mentioning
confidence: 99%
“…Cardiologists sometimes joke that it is easier to fix the heart than cure cancer; however, we all know from epidemiological data that the death toll of late cardiac toxicity among cancer survivors is substantial. It holds true not only for the old cytotoxic chemotherapy but also for many novel targeted treatments [6].…”
mentioning
confidence: 99%